DeepMind Spinout Isomorphic Labs Secures $5B Series C to Advance AI-Designed Drugs Toward Clinical Trials
Isomorphic Labs, the AI drug-discovery company spun out of DeepMind, raised $5 billion in a Series C co-led by Greenoaks and Sequoia, with Andreessen Horowitz and existing backers participating. The company builds on Alp...
Risk:
[+0.01 pp]
AGI:
[+0.01 pp]